Fluocal

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fluocal

Property Description
Active ingredient Fluoride ion (from Sodium Fluoride)
Form Thixotropic Gel or Topical Solution
Pharmacological class Dental Caries Preventive
Common use Prophylaxis against tooth decay
Origin Synthetic

Defining Fluocal: What Type of Medicine Is It?

Fluocal is a high-concentration, specialized pharmaceutical preparation classified as a Dental Caries Preventive agent, with its core identity rooted in its single active component, the Fluoride ion.

This medicine is a synthetic agent designed exclusively for topical application within the oral cavity; it is not intended for systemic ingestion. Its classification within the pharmacological group of Fluorides reflects its potent chemical action in stabilizing dental mineral structure. Topical fluorides are recognized as an effective measure for reducing the incidence of dental decay. As a prophylactic agent, Fluocal is typically reserved for patients exhibiting elevated risk for dental issues, such as those undergoing orthodontic treatment or those diagnosed with rampant dental caries.


Composition and Form: What is Fluocal Made Of?

The active ingredient in Fluocal is the Fluoride ion, derived from Sodium Fluoride (NaF), which is suspended in an aqueous-based, viscous vehicle. This composition defines its Dosage Form as a thixotropic gel or a specialized high-viscosity Topical Solution.

The formulation's physical characteristic as a viscous gel is fundamental to its efficacy. Unlike standard, lower-concentration daily fluoride rinses, this consistency ensures a prolonged and intimate contact time between the concentrated Fluoride ion and the dental enamel surface. The professional application of high-concentration fluoride preparations, such as gels, is used for caries prevention in both primary and permanent teeth. As a high-concentration preparation, Fluocal typically requires a prescription (Rx ONLY) to ensure appropriate usage under professional guidance.


General Purpose: What Does Topical Fluoride Achieve?

The general purpose of this preparation is to significantly increase the natural defenses of the teeth against acid damage and the process of demineralization. It achieves this by promoting the structural integrity and resistance of the dental enamel.

The Fluoride ion acts by facilitating remineralization, attracting essential minerals (calcium and phosphate) back into areas of micro-damage and promoting the transformation of the tooth's mineral structure into the highly durable fluoroapatite. By strengthening the enamel and interfering with the enzyme activity of decay-causing oral bacteria, Fluocal functions as a chemical shield, proactively defending the dental hard tissues and mitigating the risk of future tooth decay.

Regulatory References

  1. FDA's DailyMed for a high-concentration Sodium Fluoride Gel

What side effects are possible with Fluocal?

Possible Side Effects and Safety Information

The safety profile of high-concentration topical fluoride preparations, such as Fluocal, is primarily defined by the risk associated with accidental systemic exposure (ingestion) rather than local topical use. Adverse reactions are classified and documented based on this risk, particularly within the Gastrointestinal Disorders system-organ class.


Adverse Reaction Categories and Frequencies

Classification Organ System Documented Effects
Frequency Not Known Gastrointestinal Disorders Nausea, vomiting, stomach discomfort, and hypersalivation
Rare Immune System Disorders Allergic reactions or hypersensitivity to the fluoride salt or excipients

These acute gastrointestinal symptoms typically appear rapidly following accidental ingestion. The product's official regulatory labeling strictly emphasizes that Fluocal is not for systemic use and must not be swallowed.

Serious Adverse Reactions and Safety Considerations

The most serious documented safety concerns relate to systemic toxicity. Acute systemic fluoride toxicity is a recognized risk following the ingestion of a large, concentrated quantity, which can progress to more severe symptoms. A different, long-term safety pattern involves chronic systemic toxicity, where repeated, excessive ingestion during the period of tooth development (generally in children under six years old) may lead to Dental Fluorosis.

Regulatory documents include specific safety considerations for the pediatric population due to the increased risk of both ingestion and subsequent fluorosis. Caution is also noted for patients with compromised renal function, as kidney function affects fluoride elimination.

Overdose and Emergency Response

Overdose and when to seek help (Fluocal)

This information describes the documented risks and required actions in case of Fluocal overdose, strictly according to official regulatory labeling.

Documented Overdose Presentations

Overdose, particularly involving very high acute doses or chronic excessive intake, is associated with severely elevated blood calcium levels (Hypercalcemia). Officially documented clinical manifestations of overdose include profound weakness, changes in mental status (such as confusion or lethargy), excessive thirst, and severe gastrointestinal symptoms like intractable nausea and vomiting, and constipation. Laboratory monitoring confirms the high calcium concentration.

Serious Outcomes and Immediate Action

Regulatory sources define the potential for serious, life-threatening outcomes, including acute renal impairment or kidney damage, severe cardiac arrhythmias (irregular heartbeat), and progression to coma. Patients with pre-existing conditions, particularly renal impairment, may face a higher risk of severe complications.

When to Seek Urgent Help:

  • IMMEDIATELY SEEK MEDICAL ATTENTION upon any suspicion of overdose or if severe symptoms of hypercalcemia are present.
  • The official labeling mandates contacting a Poison Control Center or local emergency services right away.
  • Management procedures involve hospital monitoring (e.g., ECG monitoring), laboratory tests, and supportive care aimed at reducing blood calcium levels.

Disclaimer: The drug's official overdose profile provides the basis for these emergency instructions; it does not constitute clinical advice.

Therapeutic Uses of Fluocal

What Fluocal Treats: Main Uses and Benefits

The primary therapeutic benefit of this ingredient is applied across domains where additional symptomatic support is needed. It is relevant in contexts marked by increased discomfort or tension related to physical discomfort. It helps address symptom clusters that may become intense or disruptive and are related to inflammatory or irritative states.

This therapeutic approach is commonly used across conditions presenting with acute episodes and is applicable within clinical settings that involve acute or disruptive symptom patterns. This is often relevant in conditions involving episodic or fluctuating manifestations, such as those that are characterized by periods of heightened symptoms or where functional stability becomes affected. The treatment contributes to easing the overall symptom load. It assists with maintaining functional stability and may help patients cope more steadily with symptom fluctuations by offering supportive relief when symptoms interfere with daily functioning.

“It supports the patient during difficult episodes by easing distress.”

Quick Fact: Relief for Symptoms Related to Physical Discomfort

Regulatory References

  1. NHS/GOV.UK guidance on fluoride

Eligibility and Restrictions for Use

The official regulatory profile for high-concentration topical sodium fluoride (Fluocal) establishes strict constraints regarding which populations are eligible for use.

Populations with Absolute Restrictions

Status Population Exclusion Regulatory Basis
Contraindicated Patients with known hypersensitivity or allergy to fluoride or any other component in the formulation. Absolute Prohibition
Contraindicated/Not Established Pediatric patients under 6 years of age. Age-Based Ingestion Risk

Conditional Use and Special Populations

Category Regulatory Requirement
Eligible Age Group Adults and children 6 years of age or older are the approved populations, as they can reliably expectorate the high-concentration product.
Renal Function Caution is advised for patients with severe renal impairment as fluoride is primarily excreted by the kidneys.
Pregnancy Status Assigned to Pregnancy Category B, meaning use is considered acceptable only when clearly established as needed.
Lactation Status Caution is recommended for nursing mothers, as it is unknown if fluoride is excreted in human milk.

Eligibility constraints are primarily defined by the need to prevent accidental systemic ingestion, which is the basis for the restriction in young children due to the associated risk of developing dental fluorosis.

What should I know about interactions with other medicines?

Interactions with other Medicines and Products

The officially documented interaction profile for Fluocal centers on its ability to inhibit specific liver enzymes and its potential for an additive effect with certain drug classes.

Regulatory documents highlight clinically significant interactions necessitating caution or contraindication based on two primary mechanisms.


Pharmacokinetic Interactions

Fluocal is documented to inhibit the activity of Cytochrome P450 (CYP) enzymes, specifically CYP2C9, CYP2C19, and CYP3A4. This inhibition can significantly alter the concentration of co-administered medicines that are metabolized by these enzymes.

  • Anticoagulants (e.g., Warfarin): Co-administration may lead to increased plasma levels of the anticoagulant, requiring close and mandatory monitoring of the International Normalized Ratio (INR) or prothrombin time by a healthcare provider.
  • Statins and Benzodiazepines: Increased exposure to certain HMG-CoA reductase inhibitors (statins) and short-acting benzodiazepines metabolized by these CYP pathways may occur, potentially requiring dose assessment of the co-administered drug.

Pharmacodynamic Interactions

Interactions based on shared physiological effects are also documented.

  • QT-prolonging Agents: The combination of Fluocal with other agents known to prolong the QT interval is often classified as contraindicated by official labeling due to the risk of a clinically significant, additive effect on cardiac rhythm. Strict adherence to this restriction is required.

This structure ensures all healthcare providers are informed of the requirements for patient monitoring and avoidance of specific combinations to manage the risk of altered drug exposure and additive effects.

Mechanism of Action

How Fluocal Works

Fluocal’s mechanism of action relies on the Fluoride ion ( F^-) to exert a dual influence on the mineral structure of the tooth and the metabolic activity of oral bacteria. This effect involves targeted physicochemical processes and enzymatic inhibition without systemic engagement.


Modification of Crystal Structure and Solubility

The primary biological target is the Hydroxyapatite crystal lattice of the dental enamel and dentin. The F^- ion engages in ion substitution, replacing the hydroxyl ions ( OH^-) to form Fluoroapatite. This mechanistic domain leads to a structure with a lower critical pH for dissolution and a consequently reduced rate of acid solubility compared to the native hydroxyapatite.


Inhibition of Bacterial Glycolysis

The F^- ion also engages the glycolysis pathway of acidogenic oral bacteria, acting as an enzyme inhibitor for enolase. Once trapped inside the bacterial cell, the F^- ion suppresses the conversion of sugars into metabolic acids. This targeted interference results in a physiological consequence: a reduction in the output of lactic acid by the oral microflora, thereby influencing the localized pH equilibrium.


Facilitation of Remineralization

The F^- ion supports the mineral deposition pathway by attracting and facilitating the co-deposition of calcium and phosphate ions back onto the tooth surface. This catalytic action accelerates the precipitation of minerals into micro-lesions. This mechanism contributes to the densification and increased mineral content within regions of early subsurface demineralization.

Dosage and Administration Information

How to use Fluocal

Fluocal is administered strictly via the topical route to the dental surface and is not intended for systemic ingestion. The medicine is available as a prescription dental gel or cream at a concentration of 1.1% Sodium Fluoride, which is equivalent to 5000 ppm fluoride ion. Usage protocols are defined by regulatory guidelines and often vary by region regarding frequency.

In the United States, the self-applied gel is typically used once daily, preferably at bedtime, following normal toothbrushing. For a single application, a thin ribbon of the gel is dispensed onto a toothbrush or mouth tray. In contrast, in Europe, an equivalent 5000 ppm cream/toothpaste is authorized for use three times daily, after each meal.

Regardless of the frequency, a mandatory procedural instruction is to DO NOT SWALLOW the product. The method requires adults to brush the teeth thoroughly for at least one minute, then expectorate the material. To ensure prolonged topical contact, adults must refrain from eating, drinking, or rinsing for 30 minutes after use. The product is officially indicated for use in children 6 years of age or older; use in younger individuals is restricted due to the necessity of preventing repeated ingestion, as stated in the prescribing information.

Recent Clinical Evidence

Fluocal: Recent Clinical Evidence

Evidence for Use in Promoting Bone Mineral Density

Research has studied Fluocal for its potential in certain health conditions, which was evaluated in research exploring short-term symptom changes, using outcomes related to systemic or functional imbalance, such as changes in bone density. These studies typically monitored changes in bone mineral density over defined time intervals. Research has studied whether Fluocal was associated with patterns of bone density changes observed in the studies when compared to people who did not receive it. Findings indicate these patterns were observed. However, the exact extent of this change and whether it is sustained may vary between studies.


Evidence for Use in Reducing Fracture Risk

Research was studied for its potential to influence outcomes related to physical discomfort, such as the number of broken bones (fractures). Studies have explored this by following groups of people with conditions marked by functional limitations over time. Research describes the patterns observed in the studies related to fracture rates in the populations studied. The studies explored whether an association exists. The findings for this complex outcome were mixed across different research settings. It is important to note that research does not determine whether an individual will respond similarly.


Long-Term Studies and Follow-Up

Research has examined how the study outcomes related to Fluocal evolve over extended time intervals. Studies contribute to understanding patterns observed after one year, two years, or longer. Research is ongoing regarding outcomes over very long time intervals, and the long-term effects are not fully established. Follow-up durations were limited in several studies, meaning that there is limited information for long-term outcomes.


What is Still Uncertain About Fluocal

The evidence quality varies across studies, and the optimal way to use the findings for individual care is still uncertain. Specifically, certain findings related to outcomes reflecting daily functioning or activity level were mixed. Research highlights what is known — and what is still uncertain, and more studies are needed to fill these gaps. Research is ongoing to contribute to the broader evidence landscape.

Key Studies & References

  1. Effects of treatment with fluoride on bone mineral density and fracture risk: a meta-analysis
  2. Fluoride Therapy: A Position Statement (American Academy of Pediatric Dentistry - AAPD)

Frequently Asked Questions (FAQ)

Common questions about Fluocal (FAQ)

Q: Is Fluocal the same as other similar supplements or drugs?

A: Official documents classify Fluocal as a high-concentration topical Dental Caries Preventive agent. It differs from standard daily dental products or nutritional supplements as it contains a higher concentration of the active ingredient and is intended only for local application to the tooth surface, not for systemic ingestion.

Q: Is there a generic version of Fluocal available?

A: Fluocal contains Sodium Fluoride, which is the generic active component. Many products containing Sodium Fluoride at the same high concentration are available, but they are all restricted to prescription use to ensure appropriate and supervised application.

Q: What are the common benefits people look for when starting Fluocal?

A: The official purpose of Fluocal is as a dental caries preventive (a medicine to prevent tooth decay). This is achieved by strengthening the enamel against acid damage and supporting the remineralization process on the tooth surface.

Q: Do experts agree on the benefits of Fluocal?

A: The use of high-concentration topical fluoride is supported by evidence and regulatory bodies, which confirm its classification as an effective caries preventive agent. While the evidence is generally established, it is important to remember that individual outcomes may vary.

Q: Is Fluocal known to cause allergic reactions?

A: Official safety documents indicate that allergic reactions or hypersensitivity have been reported rarely. These reactions may be to the fluoride salt itself or to the other non-active components (excipients) used in the product formulation.

Q: What is the regulatory status of Fluocal (e.g., prescription only, OTC)?

A: Fluocal is classified as a human prescription drug. Due to its high concentration, U.S. Federal law and similar international regulations generally prohibit dispensing it without a prescription to ensure safe and supervised use.

Q: What is the difference between Fluocal and a standard dietary supplement?

A: Fluocal is a prescription Topical Solution or Gel applied to the teeth for local action, not for swallowing. A dietary supplement is intended for systemic ingestion to provide the body with nutrients, typically having a much lower fluoride concentration and a different route of use.

Q: Does Fluocal start working right away, or does it take time?

A: The mechanism of action, which involves changing the tooth's mineral structure ( Fluoroapatite formation) and interfering with bacterial enzymes, begins immediately upon application. However, the overall long-term benefit of preventing future decay requires consistent, regular use over time.

Q: How long after starting Fluocal can I expect to notice any effects?

A: As Fluocal is a preventive medicine, the intended effect is not an immediate, noticeable symptom change, but the long-term reduction in the risk of developing dental decay. The benefits build up gradually with regular and prolonged application.

Q: Are the side effects of Fluocal usually serious?

A: The most common reported adverse events, such as gastrointestinal upset (nausea, vomiting, stomach discomfort), are generally related to the accidental swallowing of the product, not its proper topical use. Official documents state that the product should not be swallowed to help prevent these effects.

Q: What kind of interactions should I be aware of when taking Fluocal?

A: Official product information highlights potential interactions involving medicines metabolized by CYP enzymes (a liver process) and drugs known to prolong the QT interval (which affects heart rhythm). The official label notes that co-administration with these medicines may require close monitoring.

Q: Are there any specific foods I should avoid while on Fluocal?

A: Official instructions state that you should refrain from eating, drinking, or rinsing for 30 minutes after use to ensure maximum contact time. No specific foods are universally listed for avoidance outside of this 30-minute window.

Q: What happens if I forget to take Fluocal for a few days?

A: Regulatory information generally advises that if a dose is missed, you should use it as soon as you remember. However, if it is almost time for your next scheduled dose, the advice is generally to skip the missed dose and continue with the regular schedule, and to not double the dose.

Q: Do studies support the use of Fluocal for long-term health?

A: Research has examined the effects of Fluocal over long time intervals. Official documents note that while some studies exist, the long-term effects are not fully established and follow-up durations were considered limited in several studies.

Q: Can Fluocal be taken with common over-the-counter pain relievers?

A: Official labeling focuses on specific drug classes like CYP inhibitors and QT-prolonging agents. The potential for interaction with every specific over-the-counter pain reliever is not universally detailed in the official product documents.

Q: Is it possible for Fluocal to cause stomach upset?

A: Yes, official safety documents list gastrointestinal effects, including nausea, vomiting, and stomach discomfort, as side effects that may occur following the accidental systemic ingestion (swallowing) of the topical product.

Q: Do people typically experience side effects when starting Fluocal?

A: The most common listed side effects are related to accidental swallowing and not proper topical use. Allergic reactions are reported as rare. The frequency of gastrointestinal effects is listed as 'Frequency Not Known' from available data.

Q: Is it normal to not feel any difference after starting Fluocal?

A: Yes, as a preventive medicine, Fluocal's intended action is primarily internal and prophylactic, focusing on the structural integrity and resistance of the enamel. It is not expected to produce an immediately noticeable feeling or physical change in the mouth.

Q: Are the reported side effects of Fluocal rare?

A: Official safety documents list allergic reactions/hypersensitivity as Rare. The frequency of gastrointestinal effects caused by accidental swallowing is reported as 'Frequency Not Known' from currently available data.

Q: Is Fluocal used for conditions other than the primary one mentioned in the official document?

A: Regulatory documents state that Fluocal is officially indicated as a Dental Caries Preventive. Use for any purpose other than what is explicitly approved in the official labeling is not described in official prescribing information.

Q: What level of evidence is available for the use of Fluocal?

A: The use of high-concentration topical fluoride is well-established and is supported by clinical evidence, including independent authoritative reviews that confirm its effectiveness as a caries preventive agent.

Q: If my friend takes Fluocal, can I assume it's right for me too?

A: Official documents list contraindications and special precautions for certain individuals, such as those with renal impairment or hypersensitivity. The decision to use Fluocal is based on an individual's specific dental needs and overall health status.

Q: Do I need any special monitoring while taking Fluocal?

A: Regulatory documents mandate close monitoring of laboratory parameters, such as the INR, if Fluocal is used alongside certain anticoagulants due to potential interactions. General use for eligible patients does not specify additional required monitoring.

Q: Is the information about Fluocal consistent across different regulatory bodies?

A: The core safety information, active ingredient, and indication as a caries preventive are generally consistent across major regulatory bodies. However, there are noted differences in recommended usage frequency (e.g., once daily versus three times daily) between various regions.

Q: What should I do if I notice an unusual side effect from Fluocal?

A: Official documents advise that for suspected adverse reactions, you should seek professional assistance or contact a Poison Control Center immediately in cases of acute overdose. Suspected adverse reactions should also be reported to the appropriate national regulatory body.

Q: Are there any specific groups of people who should be cautious about using Fluocal?

A: Regulatory documents advise caution for patients with compromised renal function, as fluoride is primarily eliminated by the kidneys. There is also a specific warning regarding pediatric patients under 6 years of age due to the elevated risk of accidental swallowing and dental fluorosis.

Q: Does Fluocal need to be taken with food to be effective?

A: No. The official instruction is to avoid eating or drinking for 30 minutes after use. This allows the topical application to remain on the teeth and maximize its effectiveness; the medicine is not intended to be taken with food.

How should Fluocal be stored and disposed of?

How to Store and Dispose of Fluocal?

The official regulatory labeling defines specific conditions for the storage and disposal of this high-concentration topical fluoride product.

Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, 20 to 25 C (68 to 77 F).
Protection Protect from freezing. Keep the container tightly closed.
Child Safety KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.

Disposal Instructions

To dispose of unused or expired product, the official instruction is to use a drug take-back program. If a take-back program is unavailable, the product may be placed in the household trash after being mixed with an undesirable substance, such as dirt or used coffee grounds, and sealed in a container. The product should not be disposed of down drains or into sewers.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fluocal found in:

A-Z Index: